Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer

Volume 21 - Issue 10



Meet Our Editorial Board Member promotion: free to download

Volume: 21   Issue: 10
Pp: 943-943
Flores-Mireles
DOI: 10.2174/138945012110200624100353



The Power of Biomarkers in Transforming Patients Care in Gynecologic Oncology promotion: free to download

Volume: 21   Issue: 10
Pp: 944-945
Khalid El Bairi and Mariam Amrani
DOI: 10.2174/138945012110200624104942



The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas

Volume: 21   Issue: 10
Pp: 946-961
Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan
DOI: 10.2174/1389450120666191120123612



BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer

Volume: 21   Issue: 10
Pp: 962-973
Amal Tazzite*, Hassan Jouhadi, Abdellatif Benider and Sellama Nadifi
DOI: 10.2174/1389450121666200203162541



Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas

Volume: 21   Issue: 10
Pp: 974-995
Cécile Le Page*, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher and Anne-Marie Mes-Masson
DOI: 10.2174/1389450120666191016143836



Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response

Volume: 21   Issue: 10
Pp: 996-1007
Soumaya Souid*, Dorra Aissaoui, Najet Srairi-Abid and Khadija Essafi-Benkhadir
DOI: 10.2174/1389450121666200128161733



Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers

Volume: 21   Issue: 10
Pp: 1008-1025
A. Gouri*, B. Benarba, A. Dekaken, H. Aoures and S. Benharkat
DOI: 10.2174/1389450121666200312105908



Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

Volume: 21   Issue: 10
Pp: 1026-1033
Khalid El Bairi*, Said Afqir and Mariam Amrani
DOI: 10.2174/1389450121666200425211732



Fibroblast Growth Factors as Tools in the Management of Neuropathic Pain Disorders

Volume: 21   Issue: 10
Pp: 1034-1043
Fatemeh Forouzanfar and Hamid R. Sadeghnia*
DOI: 10.2174/1389450121666200423084205